Surpassing 50 Million Units in Global Cumulative Sales Within 20 Months of Launch
233% Growth in the Last 7 Months
APR to Internalize PDRN and PN-Based Ingredient Production at Pyeongtaek Factory No. 3 by 2027

APR announced on April 2 that its Mediheal brand has surpassed cumulative global sales of 50 million units for its PDRN product line.


This achievement was reached approximately 20 months after the initial launch of the PDRN line in June 2024, representing about a 233% increase in just seven months since the cumulative sales reached 15 million units in July 2025. The company analyzed that the increase was driven by expanded sales shares not only in Korea but also in major overseas markets such as the United States and Japan.


Photo of Mediheal PDRN product line. APR

Photo of Mediheal PDRN product line. APR

View original image

The Mediheal PDRN line, centered on the PDRN Pink Peptide Ampoule, PDRN Pink Collagen Gel Mask, and PDRN Pink Tone-Up Sunscreen, has expanded its product range to include toner, serum, cleanser, and hair care products.


APR plans to accelerate the advancement of its skincare ingredient production infrastructure and expand its business portfolio. In 2027, the company aims to complete its third factory, "APR Factory No. 3," in Pyeongtaek, covering approximately 13,200 square meters, and begin full-scale production of skin booster ingredients based on PDRN and PN. Through this, APR seeks to internalize core ingredient technologies and secure competitive quality, with the strategic goal of advancing into the high-value-added skin booster market.



An APR representative said, "Reaching the milestone of 50 million units sold for the PDRN product line is evidence that Mediheal's products have been validated in the global market," adding, "Moving forward, we will enhance our business structure based on ingredient competitiveness and R&D capabilities and continue to expand our presence across the entire high-performance beauty market."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing